Aquestive Therapeutics===Anaphylm
Tracked across 2 events · 56 articles · First seen Jan 29, 2026 · Last active Apr 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Aquestive Therapeutics===Anaphylm is the subject of the New Drug Application that Aquestive Therapeutics allegedly misrepresented. Issues with its human factors in use and deployment are central to the lawsuit.
Mar 10, 2026 · 48 articles
Business
Aquestive Therapeutics===Anaphylm, Aquestive Therapeutics' sublingual film, has had its approval delayed indefinitely by the United States===Food and Drug Administration due to identified deficiencies in its New Drug Application.
Jan 29, 2026 · 8 articles
Aquestive Therapeutics
developer of
↔
Aquestive Therapeutics===Anaphylm
Aquestive Therapeutics is the developer of the drug Aquestive Therapeutics===Ana
NEWSDESK
Track Aquestive Therapeutics===Anaphylm live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard